GTS Securities’s SpringWorks Therapeutics SWTX Stock Holding History

GTS Securities’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10,275	Closed	-$483K	–	1690
2025 Q2	$483K	Buy	+10,275	New	+$457K	0.02%	673

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

GTS Securities's SWTX Position: Q3 2025 in Review

GTS Securities sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 10,275 shares — an estimated $483K sold.

GTS Securities first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $483K in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

GTS Securities reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
GTS Securities sold 10,275 SpringWorks Therapeutics shares in Q3 2025, an estimated $483K.
GTS Securities first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
GTS Securities's SpringWorks Therapeutics position peaked at $483K in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on GTS Securities's 13F filing for Q3 2025, filed 14 Nov 2025.